Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment
Clinical trial NCT00004584 · COMPLETED
Trial details
- NCT number
- NCT00004584
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1999-12-01
- Primary completion
- 2002-01-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.